Serum procalcitonin level, viral polymerase chain reaction analysis, and lower respiratory tract infection

Journal of Infectious Diseases

Volumn 209, Issue 4, 2014, Pages 631-633

  Musher, Daniel M ^a,b,c   Bebko, Serge P ^a,b   Roig, Ingrid L ^a,b  

^a Medical Care Line   (Germany)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTIONS; FEMALE; HUMANS; MALE; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 84893331348     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit579     Document Type: Letter

References (9)

1. Falsey AR, Becker KL, Swinburne AJ, et al. Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis 2013; 208:432-41.
2. Musher DM, Roig IL, Cazares G, Stager C, Logan N, Safar H. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: Results of a one-year study. J Infect 2013; 67:11-8.
3. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Amer J Resp Crit Care Med 2006; 174:84-93.
4. Schuetz P, Muller B, Christ-Crain M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2012; 9:CD007498.
5. Falsey AR, Becker KL, Swinburne AJ, et al. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note. Internat J Chron Obstructive Pulm Dis 2012; 7:127-35.
6. Daniels JM, Schoorl M, Snijders D, et al. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest 2010; 138:1108-15.
7. Roig IL, Cazares G, Rueda AM, Musher DM. Procalcitonin as a diagnostic tool to distinguish bacterial pneumonia in patients with pulmonary infiltrates [abstract 979]. Presented at: 49th Annual Meeting of the Infectious Diseases Society of America, Boston, Massachusetts, 20-23 October 2011.
8. Albrich WC, Dusemund F, Bucher B, et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL). Arch Intern Med 2012; 172:715-22.
9. Bhat N, O'Brien KL, Karron RA, Driscoll AJ, Murdoch DR, Pneumonia Methods Working G. Use and evaluation of molecular diagnostics for pneumonia etiology studies. Clin Infect Dis 2012; 54 (Suppl 2):S153-8.